Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial.
Saved in:
| Title: | Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial. |
|---|---|
| Authors: | Kolodziej M; Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland., Opalinska M; Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland., Mikolajczak R; Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland., Hubalewska-Dydejczyk A; Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland., Dedecjus M; Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland., Kowalska A; Collegium Medicum, Jan Kochanowski University, Kielce, Poland., Saracyn M; Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland.; Faculty of Medicine, University of Warsaw, Warsaw, Poland., Garnuszek P; Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland., Cieszykowska I; Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland., Januszkiewicz-Caulier J; Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland., Dlugosinska J; Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland., Durma AD; Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland.; Faculty of Medicine, University of Warsaw, Warsaw, Poland., Jozwik-Plebanek K; Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland., Mroz A; Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland.; Faculty of Medicine, University of Warsaw, Warsaw, Poland., Janiak K; Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland., Gasior-Perczak D; Collegium Medicum, Jan Kochanowski University, Kielce, Poland., Trofimiuk-Muldner M; Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland., Sowa-Staszczak A; Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland., Braziewicz J; Department of Nuclear Medicine, Holy Cross Cancer Center, Kielce, Poland., Lenda-Tracz W; Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Kacperski K; Particle Acceleration Physics and Technology Division, National Centre for Nuclear Research, Otwock, Poland.; Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Warsaw, Poland., Budzynska A; Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Warsaw, Poland., Kubik A; Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Warsaw, Poland., Pastusiak P; Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Warsaw, Poland., Chalewska W; Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland., Borkowska A; Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Cegla P; Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland., Walecka-Mazur A; Department of Endocrinology, Holy Cross Cancer Center, Kielce, Poland., Szczodry A; Department of Endocrinology, Holy Cross Cancer Center, Kielce, Poland., Kaminski G; Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Dec 01; Vol. 16, pp. 1716247. Date of Electronic Publication: 2025 Dec 01 (Print Publication: 2025). |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
